华控康泰二零二三年年报

(Stock Code: 1312)(Incorporated in the Cayman Islands with limited liability) ANNUAL REPORT2023 2581973100124133136139140144304Corporate InformationChairman’s StatementManagement Discussion and AnalysisEnvironmental, Social and Governance ReportCorporate Governance ReportDirectors’ ReportIndependent Auditor’s ReportConsolidated Statement of Profit or Loss andOther Comprehensive IncomeConsolidated Statement of Financial PositionConsolidated Statement of Changes in EquityConsolidated Statement of Cash FlowsNotes to the Consolidated Financial StatementsFinancial Summary 目錄CONTENTS As at the date of this report BOARD OF DIRECTORS Executive Directors Bai Pingyan,ChairmanChai HongjieHuang Yu,PresidentJiang Chaowen,Chief Executive Officer Independent Non-Executive Directors Chan Sze ChungZhang RuibinZhang Junxi Jack EXECUTIVE COMMITTEE Bai Pingyan,ChairmanChai HongjieHuang YuJiang Chaowen AUDIT COMMITTEE Chan Sze Chung,ChairmanZhang RuibinZhang Junxi Jack REMUNERATION COMMITTEE Zhang Ruibin,ChairmanChan Sze ChungZhang Junxi Jack NOMINATION COMMITTEE Bai Pingyan,ChairmanChan Sze ChungZhang RuibinZhang Junxi Jack RISKS MANAGEMENT COMMITTEE Zhang Junxi Jack,ChairmanJiang ChaowenChan Sze ChungZhang Ruibin SHARE DEALING COMMITTEE Bai Pingyan,ChairmanChai HongjieHuang YuJiang Chaowen INVESTMENT COMMITTEE Bai Pingyan,ChairmanChan Sze ChungZhang Ruibin PRINCIPAL BANKERS Hong Kong Fubon Bank (Hong Kong) LimitedBank of China (Hong Kong) LimitedStandard Chartered Bank (Hong Kong) LimitedThe Hongkong and Shanghai Banking Corporation Limited Mainland China Bank of Beijing Co., Ltd.China Construction Bank CorporationPing An Bank Co., Ltd.Bank of China Limited Singapore United Overseas Bank Limited REGISTERED OFFICE Windward 3Regatta Office ParkP.O. Box 1350Grand Cayman KY1-1108Cayman Islands Windward 3Regatta Office ParkP.O. Box 1350Grand Cayman KY1-1108Cayman Islands CORPORATE INFORMATION HEAD OFFICE AND PRINCIPAL PLACE OFBUSINESS 3012A12A0912A202731650027316599info@kontafarma.com.hk Room 12A09–12A20, 12A/F, Sun Hung Kai Centre30 Harbour Road, Wanchai, Hong KongTel.:2731 6500Fax:2731 6599E-mail:info@kontafarma.com.hk PRINCIPAL SHARE REGISTRAR Ocorian Trust (Cayman) LimitedWindward 3Regatta Office ParkP.O. Box 1350Grand Cayman KY1-1108Cayman Islands Ocorian Trust (Cayman) LimitedWindward 3Regatta Office ParkP.O. Box 1350Grand Cayman KY1-1108Cayman Islands BRANCH SHARE REGISTRAR IN HONG KONG 1617 Tricor Secretaries Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong CHIEF FINANCIAL OFFICER AND COMPANYSECRETARY Si Tou Man Wai INDEPENDENT AUDITOR BDO Limited SOLICITORS CFN LawyersApplebyWellington Legal STOCK CODE 1312 1312 WEBSITES http://www.kontafarma.com.hk http://www.kontafarma.com.hk On behalf of the board of directors (the “Board”) of KontafarmaChina Holdings Limited (the “Company”), I am pleased to present toyou the audited annual results of the Company and its subsidiaries(collectively, the “Group”) for the year ended 31 December 2023. RESULTS 809.1894.19.5%61.152.80.520.74 The revenue of the Group for the year ended 31 December 2023was approximately HK$809.1 million (2022: approximately HK$894.1million),representing a decrease of approximately 9.5%ascompared to the previous year. The loss for the year of the Groupwas approximately HK$61.1 million (2022: approximately HK$52.8million).The basic loss per share amounted to approximatelyHK$0.52 cent (2022: approximately HK$0.74 cent). DIVIDEND The Board has resolved not to recommend any final dividend for theyear ended 31 December 2023 (2022: Nil). Dividend Policy The Company has adopted a dividend policy in December 2018. TheCompanyconsiders stable and sustainable returns to ourshareholders to be its goal and endeavours to maintain the dividendpolicy to achieve such goal. In deciding whether to propose a dividend and in determining thedividend amount, the Board would take into account the Group’sresultsof operations,earnings performance,cashflows,financialcondition,future prospects,as well as statutory and regulatoryrestrictions on the payment of dividends, and other factors that theBoard may consider relevant. Whilst the Board will review from time to time for determination onproposed dividend with the above factors taken into account, therecan be no assurance that dividends will be declared or paid in anyparticular amount for any given period. CHAIRMAN’S STATEMENT Corporate Culture and Visions Adhering to the people-oriented philosophy, the Group extensivelyrecruitstalents from different fields,treasures our staff as ourcornerstone, insists on unity within the Group and values internalcare and communication. By actively putting the subjective initiativeof our staff into play with care and soul, the Group continuouslyenhancesteam cohesion and realizes complementary advantagesand sincere cooperation. During the new era of development, the Group will focus on thetarget of universal health. On one h